First aid for obstetric haemorrhage: the pilot study of the non-pneumatic anti-shock garment in Egypt
Article first published online: 27 FEB 2006
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 113, Issue 4, pages 424–429, April 2006
How to Cite
Miller, S., Hamza, S., Bray, E., Lester, F., Nada, K., Gibson, R., Fathalla, M., Mourad, M., Fathy, A., Turan, J., Dau, K., Nasshar, I., Elshair, I. and Hensleigh, P. (2006), First aid for obstetric haemorrhage: the pilot study of the non-pneumatic anti-shock garment in Egypt. BJOG: An International Journal of Obstetrics & Gynaecology, 113: 424–429. doi: 10.1111/j.1471-0528.2006.00873.x
- Issue published online: 5 MAY 2006
- Article first published online: 27 FEB 2006
- Accepted 4 January 2006.
- Emergency obstetric care;
- obstetric haemorrhage
Objective To compare the effect of non-pneumatic anti-shock garment (NASG) on blood loss from obstetric haemorrhage with standard management of obstetric haemorrhage.
Design Observational study of consecutive obstetric haemorrhage cases before and after introduction of the NASG.
Setting Four tertiary care maternity facilities in Egypt.
Sample The sample consisted of women with obstetric haemorrhage and signs of shock and the entry criteria were: >750 mL of blood loss and either pulse of >100 beats per minute or systolic blood pressure of <100 mmHg. A total of 158 women were in the preintervention group and 206 in the postintervention group.
Methods All the women with haemorrhage meeting the eligibility criteria were treated according to the standard protocol for 4 months (May–August 2004); blood loss was measured and recorded. The NASG was then introduced, and all the women meeting the eligibility criteria were treated according to the standard haemorrhage protocol plus the NASG for 4 months (September–December 2004).
Main outcome measures Measured blood loss collected in a closed-end, graduated, plastic, under buttocks collection drape.
Results Median measured blood loss in the drape following study entry was 50% lower in those treated with the NASG (250 versus 500 mL, P < 0.001). There was also a non-statistically significant decrease in morbidity and mortality.
Conclusions This is the first comparative study of the NASG with a standard obstetric haemorrhage treatment protocol. The NASG shows promise for management of obstetric haemorrhage, particularly in lower resource settings. Larger studies will be needed to determine if the NASG contributes to statistically significant decreases in morbidity and mortality.